Drug intelligence / Profile preview

cranberry extract

Development stage
Phase 2
Modality
Small Molecules
Administration
Oral
01

Overview

Cranberry extract is a dietary supplement derived from the fruit of the plant *Vaccinium macrocarpon* (American cranberry). It is primarily used for the prevention of urinary tract infections (UTIs), with evidence suggesting it can reduce the risk of recurrent UTIs in women by 25–30%[3][4][5]. The proposed mechanism involves proanthocyanidins and other compounds in cranberries that inhibit the adhesion of uropathogenic *Escherichia coli* to uroepithelial cells by acting as receptor analogs and altering bacterial fimbriae[6]. Other suggested uses include reducing urinary odor in incontinent patients and possible roles in cardiovascular disease risk reduction; however scientific support for these indications is limited[2][5][8]. Cranberry extract is available as juice concentrate or capsules/tablets. It is not considered effective for treating active UTIs. Adverse effects are rare but may include gastrointestinal symptoms at high doses or increased risk of kidney stones with concentrated tablets[5].

Brand names
American cranberryblack cranberryEuropean cranberrylow cranberrymossberryOxycoccus macrocarpustrailing swamp cranberryVaccinium eduleVaccinium erythrocarpumvaccinium macrocarponVaccinium occycoccusVaccinium vitis
Other names
Vaccinium macrocarpon AitonArandano AmericanoArandano rtepadorCranberryGrosse moosbeereKranbeereTsuru-kokemomo
02

Targets

P fimbriaeFimH (Type 1 fimbrial adhesin)

Beyond the preview

Go deeper on cranberry extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cranberry extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call